50% off Premium Yearly

NYSE:G
This summary was created by AI, based on 3 opinions in the last 12 months.
Genpact Ltd, symbol G-N, is a company that focuses on banking and insurance services and has shown strong growth in earnings, averaging 13% annually over the past 15 years. Currently trading at a price-to-earnings (PE) ratio of 9.7x and offering a free cash flow yield of 8.5%, Genpact appears to hold promise as a growth company. Despite a 20% decline this year attributed to fears surrounding AI, the sentiment expressed by analysts suggests that these concerns may be overstated. Recent assessments highlight that the stock has faced challenges, prompting strategies such as covering positions and adjusting stop-loss levels, indicating a cautious but watchful perspective on the stock's performance. Overall, while Genpact has experienced downturns, analysts still recognize its potential, urging a disciplined approach to investing.
Genpact Ltd is a American stock, trading under the symbol G (previously G-N on Stockchase) on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on G (previously G-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Genpact Ltd.
Genpact Ltd was recommended as a Top Pick by Brendan Caldwell on 2002-07-02. Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Genpact Ltd.
Genpact Ltd is covered by Stockchase experts and is worth watching.
On 2026-06-17, Genpact Ltd (G) stock closed at a price of $30.31.